Best adjuvant (assist) for chemotherapy | 1+1>487% |

Effectively improve chemotherapy effect, treatment, immunity |

Reduce side effects and recurrence |

Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work |

Abstract / Summary / Overview of Apoptosis

Why do cells undergo apoptosis?

The relationship between cancer cells and apoptosis

Where are the weaknesses and symptoms of cancer cells?

Are cancer cells aggressive?

Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)

Solamargine's major function mechanism:

Solamargine vs cancer

Best Chemotherapy Adjuvant (1+1>478%) Effectively improve chemotherapy effect and cure

Best adjuvant (assist) for chemotherapy | 1+1>487%

Effectively improve chemotherapy effect, treatment, immunity

Reduce side effects and recurrence

Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work

Abstract / Summary / Overview of Apoptosis

Overview of apoptosis

•Programmed cell death

•Apoptosis is a form of programmed cell death, or “cellular suicide.”

•Apoptosis is different from necrosis, in which cells die due to injury.

•Apoptosis removes cells during development, eliminates potentially cancerous and virus-infected cells, and maintains balance in the body.

Why do cells undergo apoptosis?

Basically, apoptosis is a general and convenient way to remove cells that should no longer be part of the organism.
Some cells are abnormal and could hurt the rest of the organism if they survive, such as cells with viral infections or DNA damage.
Apoptosis is part of development
In many organisms, programmed cell death is a normal part of development.

The relationship between cancer cells and apoptosis

Apoptosis can eliminate infected or cancerous cells.

When a cell’s DNA is damaged, it will typically detect the damage and try to repair it.

If the damage is beyond repair, the cell will normally send itself into apoptosis, ensuring that it will not pass on its damaged DNA.

When cells have DNA damage but fail to undergo apoptosis, they may be on the road to cancer.

However, “successful” cancer cells successfully evade the process of apoptosis.

This allows them to divide out of control and accumulate mutations (changes in their DNA).

Apoptosis is key to immune function

Apoptosis also plays an essential role in the development and maintenance of a healthy immune system.

Where are the weaknesses and symptoms of cancer cells?

The symptoms of cancer cells are in the nucleus.

The nucleus controls the outer cytoplasm, cell composition, cell viability, etc.

DNA mutations also mutate in the nucleus.

Therefore, to treat cancer cells, we must first enter the nucleus.

Let the “regulatory cell gene” mechanism enter the nucleus to regulate

Are cancer cells aggressive?

After the action of Solamargine, the aggressiveness of cancer cells is alleviated.

So after using Solamargine, many patients feel that I am half better.

Although the tumor does not disappear quickly, patients feel that the degree of aggressiveness is reduced.

Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)

Solamargine's major function mechanism:

When Solamargine enter,

Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again.

Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant.

Reduced drug resistance

When cancer cells are less resistant to drugs, chemotherapy becomes more effective.

Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.

Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?

Solamargine vs cancer

cell apoptosis.jpg

Solamargine vs cancer

The picture shows the death of cancer cells.

The black and black parts are cancer cell nuclei.

Even if the nucleus ruptures, the cancer cells will die.

The figure shows that cancer cells can cause death.

cancer cell apoptosis_01_800.jpg

The figure shows that cancer cells can cause death.

The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.

The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.

The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.

Best Chemotherapy Adjuvant (1+1>487%) Effectively improve chemotherapy effect and treatment

ANTI-CANCER

Patent protection in 32 nations.

A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells.

A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells

solamargine combined treatment therapy_01_800.jpg

SR-T100 combination therapy with effective result against breast cancer cells.

solamargine combined treatment therapy_03R12_800.jpg

Combination Therapy | Research results for lung cancer cells.

A. Chemotherapy (100μM), 16% of cancer cell apoptosis.

B. Alone SM (4.8μM), 28% of cancer cell apoptosis.

C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis.

D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis.

SM has a clearing effect better than Chemotherapy.

The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells.

SM (4.8μM) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times).

SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times)

Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004

The best solution for cancer cells

Solamargine Q&A (English)

Cancer Medical Care | Side Effects of Chemotherapy | Improve Anemia | Improve Low Red Blood Cells | Improve Low Hemoglobin (Decrease/Decrease/Decrease/Insufficiency)

Cancer Medical Care | Chemotherapy by-products | Leukopenia | Neutropenia

Cancer Medical Care | Chemotherapy Side Effects| Improve Bleeding| Improve Platelet Decrease| Improve Platelet Deficiency| Improve Platelet Low| Improve Thrombocytopenia

Cancer Medical Care | Six indicators of physical health self-assessment: sleep, appetite, excretion, physical strength, mental strength, and psychology (emotion, mind)

Chemotherapy | Increase cure rate
Reduce cancer recurrence
Apoptotic (Correct/ Guide) bad behavior
Cure all diseases | Panacea | Package health
How to Longevity?
Want to Change?
Life Above All | Release life is best for oneself (me / yourself)
Eliminate misfortune!
Good affinities with others.
Beauty in Nature

survival rate | cancer | Contents
survival rate | cancer | Etymology and definitions
survival rate | cancer | Signs and symptoms
survival rate | cancer | Local symptoms
survival rate | cancer | Systemic symptoms
survival rate | cancer | Metastasis
survival rate | cancer | Causes
survival rate | cancer | Chemicals
survival rate | cancer | Diet and exercise
survival rate | cancer | Infection
survival rate | cancer | Radiation
survival rate | cancer | Heredity
survival rate | cancer | Physical agents
survival rate | cancer | Hormones
survival rate | cancer | Autoimmune diseases
survival rate | cancer | Pathophysiology
survival rate | cancer | Genetics
survival rate | cancer | Epigenetics
survival rate | cancer | Metastasis
survival rate | cancer | Metabolism
survival rate | cancer | Diagnosis
survival rate | cancer | Classification
survival rate | cancer | Prevention
survival rate | cancer | Dietary
survival rate | cancer | Medication
survival rate | cancer | Vaccination
survival rate | cancer | Screening
survival rate | cancer | Recommendations
survival rate | cancer | Genetic testing
survival rate | cancer | Management
survival rate | cancer | Cancer
survival rate | cancer | Radiation
survival rate | cancer | Surgery
survival rate | cancer | Palliative care
survival rate | cancer | Immunotherapy
survival rate | cancer | Laser therapy
survival rate | cancer | Alternative medicine
survival rate | cancer | Prognosis
survival rate | cancer | Epidemiology
survival rate | cancer | History
survival rate | cancer | Society and culture
survival rate | cancer | Economic effect
survival rate | cancer | Workplace
survival rate | cancer | Research
survival rate | cancer | Pregnancy
survival rate | cancer | Other animals
survival rate | cancer | Notes
survival rate | cancer | Further reading
survival rate | cancer | External links
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Contents
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Etymology and definitions
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Signs and symptoms
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Local symptoms
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Systemic symptoms
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Metastasis
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Causes
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Chemicals
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Diet and exercise
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Infection
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Radiation
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Heredity
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Physical agents
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Hormones
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Autoimmune diseases
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Pathophysiology
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Genetics
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Epigenetics
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Metastasis
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Metabolism
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Diagnosis
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Classification
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Prevention
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Dietary
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Medication
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Vaccination
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Screening
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Recommendations
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Genetic testing
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Management
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Chemotherapy
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Radiation
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Surgery
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Palliative care
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Immunotherapy
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Laser therapy
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Alternative medicine
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Prognosis
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Epidemiology
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | History
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Society and culture
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Economic effect
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Workplace
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Research
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Pregnancy
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Other animals
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Notes
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | Further reading
Ovarialtumor mit niedrigem bösartigen Potenzial | Überlebensrate | External links